Valeant, Pershing go hostile in $53.8 billion Allergan bid – Reuters

Reuters
(Reuters) – Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker’s shareholders, and Pershing Square called for a meeting to turn over the target company’s board in a battle that …
Bill Ackman Enters Attack Mode In Valeant-Allergan Takeover FightForbes
Midday movers: Allergan, Valeant, US Steel & moreCNBC.com
Pershing Seeks Changes to Allergan Board to Push SaleBloomberg
Los Angeles TimesWall Street JournalFox Business
all 63 news articles

…read more

Source: Business News From Google News

Leave a Comment